These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23970379)

  • 1. Targeting autophagy potentiates the apoptotic effect of histone deacetylase inhibitors in t(8;21) AML cells.
    Torgersen ML; Engedal N; Bøe SO; Hokland P; Simonsen A
    Blood; 2013 Oct; 122(14):2467-76. PubMed ID: 23970379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.
    Barbetti V; Gozzini A; Cheloni G; Marzi I; Fabiani E; Santini V; Dello Sbarba P; Rovida E
    Epigenetics; 2013 Feb; 8(2):210-9. PubMed ID: 23321683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
    Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
    J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy: friend or foe in the treatment of fusion protein-associated leukemias?
    Torgersen ML; Simonsen A
    Autophagy; 2013 Dec; 9(12):2175-7. PubMed ID: 24145192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid triggers differentiation and apoptosis in AML1/ETO-positive leukemic cells specifically.
    Zapotocky M; Mejstrikova E; Smetana K; Stary J; Trka J; Starkova J
    Cancer Lett; 2012 Jun; 319(2):144-153. PubMed ID: 22261333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An activated receptor tyrosine kinase, TEL/PDGFbetaR, cooperates with AML1/ETO to induce acute myeloid leukemia in mice.
    Grisolano JL; O'Neal J; Cain J; Tomasson MH
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9506-11. PubMed ID: 12881486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid may exerts its cytotoxic effect through rassf1a expression induction in acute myeloid leukemia.
    Davood ZA; Shamsi S; Ghaedi H; Sahand RI; Mojtaba G; Mahdi T; Reza M; Ebrahimi MJ; Miri-Moosavi RS; Boosaliki S; Davood OM
    Tumour Biol; 2016 Aug; 37(8):11001-6. PubMed ID: 26894600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
    Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L
    Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hematopoietic Transcription Factors RUNX1 and ERG Prevent AML1-ETO Oncogene Overexpression and Onset of the Apoptosis Program in t(8;21) AMLs.
    Mandoli A; Singh AA; Prange KHM; Tijchon E; Oerlemans M; Dirks R; Ter Huurne M; Wierenga ATJ; Janssen-Megens EM; Berentsen K; Sharifi N; Kim B; Matarese F; Nguyen LN; Hubner NC; Rao NA; van den Akker E; Altucci L; Vellenga E; Stunnenberg HG; Martens JHA
    Cell Rep; 2016 Nov; 17(8):2087-2100. PubMed ID: 27851970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of leukemia-associated fusion proteins increases sensitivity to histone deacetylase inhibitor-induced DNA damage and apoptosis.
    Petruccelli LA; Pettersson F; Del Rincón SV; Guilbert C; Licht JD; Miller WH
    Mol Cancer Ther; 2013 Aug; 12(8):1591-604. PubMed ID: 23536727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZFP36L2, a novel AML1 target gene, induces AML cells apoptosis and inhibits cell proliferation.
    Liu J; Lu W; Liu S; Wang Y; Li S; Xu Y; Xing H; Tang K; Tian Z; Rao Q; Wang M; Wang J
    Leuk Res; 2018 May; 68():15-21. PubMed ID: 29518627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of AML1-ETO modulators by chemical genomics.
    Corsello SM; Roti G; Ross KN; Chow KT; Galinsky I; DeAngelo DJ; Stone RM; Kung AL; Golub TR; Stegmaier K
    Blood; 2009 Jun; 113(24):6193-205. PubMed ID: 19377049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors.
    Bots M; Verbrugge I; Martin BP; Salmon JM; Ghisi M; Baker A; Stanley K; Shortt J; Ossenkoppele GJ; Zuber J; Rappaport AR; Atadja P; Lowe SW; Johnstone RW
    Blood; 2014 Feb; 123(9):1341-52. PubMed ID: 24415537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemia.
    Bug G; Schwarz K; Schoch C; Kampfmann M; Henschler R; Hoelzer D; Ottmann OG; Ruthardt M
    Haematologica; 2007 Apr; 92(4):542-5. PubMed ID: 17488665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells.
    Wang J; Saunthararajah Y; Redner RL; Liu JM
    Cancer Res; 1999 Jun; 59(12):2766-9. PubMed ID: 10383127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells.
    Barbetti V; Gozzini A; Rovida E; Morandi A; Spinelli E; Fossati G; Mascagni P; Lübbert M; Dello Sbarba P; Santini V
    Oncogene; 2008 Mar; 27(12):1767-78. PubMed ID: 17891169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting miR-193a-AML1-ETO-β-catenin axis by melatonin suppresses the self-renewal of leukaemia stem cells in leukaemia with t (8;21) translocation.
    Zhou B; Ye H; Xing C; Liang B; Li H; Chen L; Huang X; Wu Y; Gao S
    J Cell Mol Med; 2019 Aug; 23(8):5246-5258. PubMed ID: 31119862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells.
    Gilardini Montani MS; Granato M; Santoni C; Del Porto P; Merendino N; D'Orazi G; Faggioni A; Cirone M
    Cell Oncol (Dordr); 2017 Apr; 40(2):167-180. PubMed ID: 28160167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dexamethasone and vorinostat cooperatively promote differentiation and apoptosis in Kasumi-1 leukemia cells through ubiquitination and degradation of AML1-ETO].
    Chen LP; Zhang JW; Xu FM; Xing HY; Tian Z; Wang M; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):741-4. PubMed ID: 24103869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathway.
    Yaseen A; Chen S; Hock S; Rosato R; Dent P; Dai Y; Grant S
    Mol Pharmacol; 2012 Dec; 82(6):1030-41. PubMed ID: 22923501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.